Cargando…
Substandard anti-malarial drugs in Burkina Faso
BACKGROUND: There is concern about an increasing infiltration of markets by substandard and fake medications against life-threatening diseases in developing countries. This is particularly worrying with regard to the increasing resistance development of Plasmodium falciparum against affordable anti-...
Autores principales: | Tipke, Maike, Diallo, Salou, Coulibaly, Boubacar, Störzinger, Dominic, Hoppe-Tichy, Torsten, Sie, Ali, Müller, Olaf |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426704/ https://www.ncbi.nlm.nih.gov/pubmed/18505584 http://dx.doi.org/10.1186/1475-2875-7-95 |
Ejemplares similares
-
Access to malaria treatment in young children of rural Burkina Faso
por: Tipke, Maike, et al.
Publicado: (2009) -
Is there evidence of anti-malarial multidrug resistance in Burkina Faso?
por: Rasmussen, Charlotte, et al.
Publicado: (2021) -
Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso
por: Mandi, Germain, et al.
Publicado: (2008) -
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023) -
Deep sequencing analysis of acute conjunctivitis in Burkina Faso, Africa
por: Bountogo, Mamadou, et al.
Publicado: (2022)